伪基因酶ERBB3的转激活突变
Marika K A Koivu1,2,3, Deepankar Chakroborty1,2,3, Tomi T Airenne4
1Institute of Biomedicine, and Medicity Research Laboratories, University of Turku, Turku, 20520, Finland.
Oncogene
|May 28, 2024
概括
这项研究选了成千上万的ERBB3突变,确定了18个驱动癌症的突变. 这些ERBB3变种显示出与现有的ERBB抑制剂药物向治疗的潜力.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- ERBB家族受体氨酸激酶在癌症中至关重要,ERBB3是一种已知通过ERBB2异构体传递信号的伪激酶.
- 在癌症中发现的大多数体质ERBB3变异具有未知的意义,阻碍了向治疗的发展.
研究的目的:
- 进行无偏见的功能遗传学选,以识别转化ERBB3突变.
- 评估ERBB3变异的致癌潜力及其对向疗法的影响.
主要方法:
- 利用iSCREAM (激活突变的体外选) 平台并行选数千个ERBB3突变.
- 在Ba/F3,NIH 3T3和MCF10A细胞系中验证了已识别的突变,评估了单个变异和双重组合.
- 使用trastuzumab,pertuzumab和neratinib进行药物敏感性测试.
主要成果:
- 确定了18个具有转化潜力的ERBB3突变.
- 已确认既已知又新的转换ERBB3误解突变,单独或集体运作.
- 证明了这些转变ERBB3变异与特定的ERBB抑制剂药物可起作用.
结论:
- 这一全面的屏幕揭示了对ERBB3瘤驱动因素的新见解.
- 已识别的ERBB3变种代表了ERBB抑制剂治疗的潜在生物标志物,为癌症治疗提供了新的途径.
相关概念视频
PI3K/mTOR/AKT Signaling Pathway
3.5K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
3.5K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
The Ras Gene
6.2K
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
Ras is a...
6.2K
Receptor Tyrosine Kinases
12.7K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.7K
MAPK Signaling Cascades
5.4K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.4K
Cancer-Critical Genes I: Proto-oncogenes
8.8K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.8K


